logo-loader

ISC appoints new president for ESC Corporate Services business

Published: 13:15 11 Dec 2023 GMT

Information Services Corporation - ISC announces new president for ESC Corporate Services business

Information Services Corporation (TSX:ISV) told investors that it has appointed Jeff Fallowfield to take over as president of its ESC Corporate Services subsidiary from January 1, 2024, replacing Clare Colledge will step down from the role at the end of the year.

The company noted that Fallowfield has over 30 years of leadership experience, including eight years as president of Corporate Development at LGM Financial Services and five years at HSBC as a senior vice president in the bank’s Auto Financing division.

At ESC, ISC said Fallowfield will focus on leveraging the business’s best-in-class products and solutions and customer service to facilitate ongoing organic growth, maintain operational stability, and support process improvement to ensure its continued success.

“Since stepping into my role as President & CEO of ISC, ensuring that we have the right talent at various levels of the enterprise as well as a robust succession plan for key positions has been a critical focus for me. Today’s announcement reflects that plan,” ISC president and CEO Shawn Peters commented in a statement.

“Clare has led ESC through a period of strong growth and I want to thank her for her contributions during that time. I am confident that Jeff is well positioned to lead our next phase of planned, strong growth as both a champion of excellence at ESC and as a member of our senior leadership team.”

Headquartered in Canada, ISC is a leading provider of registry and information management services for public data and records. 

Contact the author at [email protected]

Immunic Therapeutics reaches major milestone with completion of ENSURE Trial...

Immunic Therapeutics Chief Medical Officer Dr Andreas Muehler joined Steve Darling from Proactive to announce two major developments for the company’s lead drug candidate, vidofludimus calcium (IMU-838)—a nuclear receptor-related 1 (Nurr1) activator currently being investigated for the treatment...

2 days, 14 hours ago
OSZAR »